REPVIT UK LTD was created in 2021 to market and commercialise an innovative diagnostic platform for both virus and bacterial infection. The REPViT device concept is a rapid Nucleic Acid Test (NAT) equivalent to PCR in a single-use handheld over the counter test format, similar to a pregnancy test. The aim of REPViT is to offer fast, affordable and easy to use diagnostic solutions for consumers and professionals to detect SARS-CoV-2, Influenza and other viruses and bacteria at home and on the go, in less than 15 minutes using saliva.